4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-015741
Options or other derivatives
- Chief Medical Officer acquired 2,686,728 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Norry Elliot Chief Medical Officer | 2025-02-20 | Grant or award · Option to purchase Ordinary Shares | +1,612,032 | 1,612,032 | D | ||
| Norry Elliot Chief Medical Officer | 2025-02-20 | Grant or award · Option to purchase Ordinary Shares | +1,074,696 | 1,074,696 | D | ||
Loading xslF345X05/tm257186-2_4seq1.xml…